Generation Bio Co R&D Deep Dive Transcript
It's really a pleasure to bring together two discoveries which had the chance to announce over the last couple of weeks around immune-quiet DNA. On the one hand, a novel cargo, which can leverage a broad set of delivery options on the one hand; and on the other, a unique cell targeted lipid nanoparticle delivery system, a new delivery system, which can leverage multiple cargoes.
The opportunity today is for us to give you the full voiceover of two presentations around these technologies that were given in close scientific settings. And today is an opportunity for you to hear the full voiceover behind these presentations as well as to put the depth of the investments that we've made in our platform into context over the next several presentations.
So Generation Bio is bringing DNA to non-viral genetic medicines. And writing the next chapter of non-viral genetic medicines really depends on the strength and depth of the preceding work. And those first chapters of non-viral genetic medicine have been written in RNA. Beginning with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |